Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Mpsv-acyw

Phase 3

ZZhejiang Provincial Center for Disease Control and Prevention

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Meningococcal MeningitisNot yet recruiting

Meningococcal MeningitisPhase 3

Not yet recruiting

Timeline

Expected Milestones

Q4 2027

ApprovedNot yet recruiting

Meningococcal Meningitis

NCT07885371

Clinical

Trials by Indication[1]

Meningococcal Meningitis1 trial

Single-center, Open-label Study: Immunogenicity and Safety Observation After Vaccination With ACYW135 Meningococcal Polysaccharide Vaccine in Junior High School Students Aged 13-15 Years

Not yet recruiting·ZZhejiang Provincial Center for Disease Control and Prevention·Approved·NCT07885371·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Mpsv-acyw. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Mpsv-acyw. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Zhejiang Provincial Center for Disease Control and Prevention company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 3[1]
Company: ZZhejiang Provincial Center for Disease Control and Prevention

Related News